Robert Shawah
Fondatore presso ACURX PHARMACEUTICALS, INC.
Patrimonio netto: 425 700 $ in data 30/06/2024
Posizioni attive di Robert Shawah
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ACURX PHARMACEUTICALS, INC. | Fondatore | 01/07/2017 | - |
| Direttore Finanziario/CFO | 01/07/2017 | - | |
| Comptroller/Controller/Auditor | 01/07/2017 | - |
Storia della carriera di Robert Shawah
Precedenti posizioni note di Robert Shawah
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Ameri100 Holdco, Inc.
 Ameri100 Holdco, Inc. MiscellaneousMiscellaneous Ameri100 Holdco, Inc. operates as an investment holding company. The company is headquartered in Delaware. | Direttore/Membro del Consiglio | 01/08/2018 | 01/12/2018 |
Dipexium Pharmaceuticals, Inc.
 Dipexium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dipexium Pharmaceuticals, Inc. is a late stage pharmaceutical company, which is focused on the development and commercialization of Locilex, a potent and broad spectrum topical antibiotic peptide for the treatment of mild and moderate skin and skin structure infections. The company was founded by Robert J. DeLuccia and David P. Luci on January 14, 2010 and is headquartered in New York, NY. | Comptroller/Controller/Auditor | 01/03/2014 | 01/04/2017 |
| Treasurer | 01/03/2014 | 01/04/2017 | |
| Baldwin Pearson & Co., Inc. | Corporate Officer/Principal | 01/01/2005 | 01/01/2013 |
Formazione di Robert Shawah
| Bucknell University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
Posizioni
| Comptroller/Controller/Auditor | 2 |
| Treasurer | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
| Miscellaneous | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ACURX PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Dipexium Pharmaceuticals, Inc.
Dipexium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dipexium Pharmaceuticals, Inc. is a late stage pharmaceutical company, which is focused on the development and commercialization of Locilex, a potent and broad spectrum topical antibiotic peptide for the treatment of mild and moderate skin and skin structure infections. The company was founded by Robert J. DeLuccia and David P. Luci on January 14, 2010 and is headquartered in New York, NY. | Health Technology |
Ameri100 Holdco, Inc.
Ameri100 Holdco, Inc. MiscellaneousMiscellaneous Ameri100 Holdco, Inc. operates as an investment holding company. The company is headquartered in Delaware. | Miscellaneous |
| Baldwin Pearson & Co., Inc. |
- Borsa valori
- Insiders
- Robert Shawah
- Esperienza
